QT Imaging Holdings (QTI)
NASDAQ:QTI
Want to see QTI full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.22Last Year’s EPS
-0.42Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed meaningful commercial, regulatory and clinical progress — including 133% year-over-year revenue growth, shipment increases, substantial multi-year distributor contracts, new CPT code approval, FDA enhancements clearance, UAE clearance, product/software advancements and improved GAAP loss and EBITDA trends. However, the company also faces margin compression (gross margin down from 65% to 41%), higher operating expenses and adjusted EBITDA weakness, modest cash on hand ($7.0M) versus ongoing quarterly cash burn (~$3.7M), and higher borrowing costs following a loan interest rate increase to 12%. Regulatory timing (e.g., SFDA) and geopolitical shipping disruptions also present execution risks. On balance, the positive commercial momentum, validated clinical data and significant distribution commitments outweigh near-term financial and operational headwinds, though execution on margin improvement, cash management and international approvals will be important to realize guidance.Company Guidance
Strong Revenue Growth
Revenue for Q1 2026 was $6.5 million, up 133% year-over-year versus Q1 2025, driven primarily by increased scanner shipments (13 units in Q1 2026 vs 6 units in Q1 2025).
Increased Unit Shipments and Commercial Execution
Shipped 13 QT Breast Acoustic CT systems during the quarter, in line with commercial distribution commitments (up from 6 units in Q1 2025, an increase of ~117%), reflecting growing commercial activity domestically and internationally.
Affirmed 2026 Revenue Guidance
Company reaffirmed 2026 revenue expectation of approximately $39 million, which would be more than double 2025 revenue, based on contracted distributor minimum order quantities and early monetization of cloud services.
Material Distribution Contracts
Significant distributor commitments: NXC Imaging contracted 60 scanners for 2026; Gulf Medical contracted 20 scanners in 2026 (32 in 2027, 40 in 2028) representing a total exceeding $51 million; Al Naghi Medical contracted 7 scanners in 2026 (16 in 2027, 20 in 2028) representing approximately $24 million — indicating multi-year channel demand and committed backlog (~$75M+ in aggregate from Gulf and Al Naghi).
Regulatory and Reimbursement Milestones
Achieved a new Category III CPT code approval by the American Medical Association effective Jan 1, 2027 (supporting standardized reporting, utilization tracking and reimbursement pathways); received FDA 510(k) clearance for scanner enhancements improving posterior breast visualization; secured UAE classification and clearance for scanner and SaaS platform under Al Naghi distribution.
Product and Software Advancements
Launched QT Imaging-Olea Viewer (multi-modality imaging and longitudinal review) and released software version 4.5.0 with a reported ~40–50% improvement in reflection image resolution (X, Y and Z), improving spatial resolution and calcification detection capability.
Clinical Validation and Advisory Strengthening
Growing clinical evidence: a Mayo Clinic prospective feasibility study showed absolute agreement between QTscan and MRI for supplemental screening in high-risk women; Sunnybrook results being prepared for manuscript demonstrating precise volumetric therapy monitoring. Added senior clinical and medical advisers (Dr. Mary Yamashita and Dr. Barry Roseman) to support clinical strategy, training and real-world deployment.
Improved Loss and EBITDA Trends
Net loss improved substantially to $3.4 million in Q1 2026 from $11.1 million in Q1 2025 (approximate 69% reduction). EBITDA improved to negative $2.5 million from negative $10.4 million year-over-year, indicating progress toward operating leverage.
Debt Maturity Extended
Senior secured term loan with Lynrock Lake ($10.1 million) had its maturity extended by two years from March 31, 2027 to March 31, 2029, providing additional financial flexibility.
QTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
QTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $7.59 | $6.32 | -16.73% |
Mar 25, 2026 | $6.57 | $6.90 | +5.02% |
Nov 10, 2025 | $6.48 | $6.26 | -3.40% |
Aug 07, 2025 | $5.16 | $5.52 | +6.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does QT Imaging Holdings (QTI) report earnings?
QT Imaging Holdings (QTI) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
What is QT Imaging Holdings (QTI) earnings time?
QT Imaging Holdings (QTI) earnings time is at Aug 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QTI EPS forecast?
QTI EPS forecast for the fiscal quarter 2026 (Q2) is -0.22.